Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  74 results for "Korman,%20Gordon"

Your Filters

Subject : melanoma Filter by : Keyword
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nivolumab plus ipilimumab in advanced melanoma.

  • Authors : Wolchok JD; Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. ; Kluger H

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2013 Jul 11; Vol. 369 (2), pp. 122-33. Date of Electronic Publication: 2013 Jun 02.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab.

  • Authors : Graziani G; Pharmacology Section, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. .; Lisi L

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/genetics

  • Source: Experientia supplementum (2012) [Exp Suppl] 2022; Vol. 113, pp. 295-350.Publisher: Springer Basel AG Country of Publication: Switzerland NLM ID: 101738007 Publication Model: Print Cited Medium: Print ISSN: 1664-431X

Record details

Read More Add to Saved list
×
Academic Journal

Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma.

  • Authors : LoRusso PM; Department of Medical Oncology, Yale University, New Haven, CT, USA.; Schalper K

Subjects: Immunotherapy* ; Molecular Targeted Therapy*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism

  • Source: Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2020 May; Vol. 33 (3), pp. 390-402. Date of Electronic Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma.

Subjects: PEMETREXED; CISPLATIN; ARGININE deiminase

  • Source: Pigment Cell & Melanoma Research; Jul2022, Vol. 35 Issue 4, p461-470, 10p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma.

Subjects: ADIPOGENESIS; T-cell exhaustion; MONOCLONAL antibodies

  • Source: American Journal of Physiology: Endocrinology & Metabolism; Mar2024, Vol. 326 Issue 3, pE341-E350, 10p

Record details

Read More Add to Saved list
×
Academic Journal

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma.

Subjects: IMMUNE checkpoint inhibitors; NUCLEAR magnetic resonance spectroscopy; POSITRON emission tomography

  • Source: International Journal of Molecular Sciences; Feb2024, Vol. 25 Issue 3, p1725, 21p

Record details

Read More Add to Saved list
×
Academic Journal

Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.

Subjects: PRECANCEROUS conditions; SKIN cancer; IMIQUIMOD

  • Source: International Journal of Molecular Sciences; Jul2023, Vol. 24 Issue 13, p10835, 20p

Record details

Read More Add to Saved list
×
Academic Journal

Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.

Subjects: MELANOMA prognosis; DENDRITIC cells; CANCER chemotherapy

  • Source: Cancers; Apr2023, Vol. 15 Issue 8, p2206, 26p

Record details

Read More Add to Saved list
×
Academic Journal

Immunotherapy in Melanoma: Recent Advances and Future Directions.

Subjects: MELANOMA prognosis; PROGRAMMED cell death 1 receptors; IMMUNE checkpoint inhibitors

  • Source: Cancers; Feb2023, Vol. 15 Issue 4, p1106, 18p

Record details

Read More Add to Saved list
×
Academic Journal

Helper Innate Lymphoid Cells—Unappreciated Players in Melanoma Therapy.

Subjects: MELANOMA treatment; DRUG efficacy; IMMUNE checkpoint inhibitors

  • Source: Cancers; Feb2023, Vol. 15 Issue 3, p933, 18p

Record details

Read More Add to Saved list
×
  • 1-10 of  74 results for "Korman,%20Gordon"